Concept Medical Inc. products

Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Upon inflation of MagicTouch SCB at target site, nanocarriers with Sirolimus drug inside gets transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, nanocarriers mimics the body lipids and liberates Sirolimus; The sub-micron sized Sirolimus drug particles penetrate the deepest layer of the vessel over a period.

Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Encapsulated Sirolimus is coated on stent and parts of balloon; Upon implantation of Abluminus NP at target site, Nanocarriers with Sirolimus drug from stent and parts of balloon get transferred to the vessel wall following the principle of co-efficient diffusion; Upon body pH variation, Nanocarriers mimics the body lipids and liberates Sirolimus; The sub-micron sized Sirolimus drug particles penetrate the deepest layer of the vessel over a period.